Material Agreements

IR-Med, Inc. entered into Securities Purchase Agreement with certain investors valued at aggregate gross proceeds of $43,619 (effective 2026-02-04).

“On February 4, 2026, IR-Med, Inc. (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain investors (each an “Investor” and, collectively, the “Investors”), pursuant to which the Company agreed to issue and sell, in a private placement offering (the “Offering”), an aggregate of 14,070,644 shares of the Company’s common stock, par value $0.001 per share, (the “Common Stock”), at a per share price of $0.0031 and a warrant to purchase up to an additional 7,035,322 shares of Common Stock (the “Warrants”) at a per share exercise price of $0.03 (the “Exercise Price”).”

Ridgepost Capital, Inc. entered into Purchase Agreement with certain entities affiliated with Stellus Capital Management, LLC and certain direct and indirect equityholders of Stellus valued at $125,000,000 in cash and 11,770,245 membership units (effective 2026-02-04).

“On February 4, 2026, P10 Intermediate Holdings LLC, a Delaware limited liability company (“Purchaser”) and a subsidiary of P10, Inc., a Delaware corporation (the “Company”), entered into an interest purchase agreement (the “Purchase Agreement”) with certain entities (together, the “Sellers”) affiliated with Stellus Capital Management, LLC, a Delaware limited liability company (“Stellus”), and certain direct and indirect equityholders of Stellus, pursuant to which, subject to the satisfaction or waiver of specified conditions, Purchaser would acquire all of the issued and outstanding equity interests of Stellus (the “Transaction”).”

NKGen Biotech, Inc. amended Alpine Third Amendment with AlpineBrook Capital GP I Limited valued at $251,000 (effective 2026-01-30).

“On January 30, 2026, NKGen Biotech, Inc. (the “Company”) and NKGen Operating Biotech, Inc., a Delaware corporation (together with the Company, the “Borrowers”), entered into a third amendment (the “Alpine Third Amendment”) to that certain secured promissory note with AlpineBrook Capital GP I Limited, dated January 5, 2026”

Fidelity Wise Origin Bitcoin Fund entered into Custodial Services Agreement with BitGo Bank & Trust, N.A. (effective 2026-02-02).

“On February 2, 2026, Fidelity Wise Origin Bitcoin Fund (the “Trust”) and BitGo Bank & Trust, N.A. (“BitGo”) entered into a Custodial Services Agreement (the “Agreement”).”

COLLECTIVE ACQUISITION CORP. entered into Purchase and Sponsor Handover Agreement with Collective Acquisition Sponsor LLC valued at $2,000,000 (effective 2026-01-30).

“On January 30, 2026, Collective Acquisition Sponsor LLC, a Delaware limited liability company (the “ New Sponsor ”), Dune Acquisition Corporation II, a Cayman Islands exempted company (the “ SPAC ”), Dune Acquisition Holdings II LLC, a Delaware limited liability company (the “ Sponsor ”), Carter Glatt, as the managing member of Sponsor (the “ Sponsor Member ”), certain members of the Sponsor named as signatories thereto (the “ Non-Managing Members ”) and certain other institutional investors signatories thereto (the “ Non-Managing Investors ”, together with the Non-Managing Members and the Sponsor Member, the “ Old Sponsor Members ”) entered into a Purchase and Sponsor Handover Agreement (the “ Purchase Agreement ”) pursuant to which New Sponsor has agreed to purchase from the Sponsor, an aggregate of (i) 4,475,000 Class B ordinary shares, $0.0001 par value per share and (ii) 1,000,000 private placement warrants of the SPAC (the “ Transferred Interests ”), for an aggregate purchase pri”

Colombier Acquisition Corp. III entered into Underwriting Agreement with Roth Capital Partners, LLC (effective 2026-02-03).

“An Underwriting Agreement, dated February 3, 2026, by and between the Company and Roth Capital Partners, LLC ("Roth"), as the representative of the several underwriters”

LEE ENTERPRISES, Inc terminated Rights Agreement with Equiniti Trust Company, LLC valued at Amendment No. 2 terminated the Rights Agreement by advancing Final Expiration Time to 5:00 P.M., New (effective 2026-02-04).

“On February 4, 2026, Lee Enterprises, Incorporated (the "Company") and Equiniti Trust Company, LLC (the "Rights Agent") entered into Amendment No. 2 ("Amendment No. 2") to the Rights Agreement, dated as of March 28, 2024, by and between the Company and the Rights Agent (as amended by Amendment No. 1 to the Rights Agreement, dated as of March 26, 2025, the "Rights Agreement"). Amendment No. 2 terminated the Rights Agreement by advancing the Final Expiration Time (as defined in the Rights Agreement) to 5:00 P.M., New York City time, on February 4, 2026.”

LEE ENTERPRISES, Inc entered into Second Amendment to Credit Agreement with BH Finance LLC valued at amended Credit Agreement, dated January 29, 2020, reducing applicable margin on term loan from 9.00% (effective 2025-12-30).

“As previously disclosed, on December 30, 2025, the Company entered into the Second Amendment to Credit Agreement (the "Credit Agreement Amendment"), which amended the Company's existing Credit Agreement, dated January 29, 2020 (as amended by that Waiver and Amendment dated May 1, 2025), with BH Finance LLC.”

LEE ENTERPRISES, Inc entered into Registration Rights Agreement with the Investors valued at Company agreed to provide Investors certain customary registration rights, including registration of (effective 2026-02-05).

“In connection with the Closing (as defined below), on February 5, 2026, as previously disclosed, the Company entered into a registration rights agreement (the "Registration Rights Agreement") with the Investors (as defined below).”

ABM INDUSTRIES INC /DE/ amended First Amendment with Bank of America, N.A. as Administrative Agent and the lenders signatory thereto valued at $255.0 million (effective 2026-02-03).

“On February 3, 2026, ABM Industries Incorporated (the “Company”) entered into the First Amendment (the “Amendment”), by and among the Company, ABM Aviation UK Limited, a company incorporated and registered in England and Wales as a private company limited by shares and a subsidiary of the Company (“ABM UK”), each of the other subsidiaries of the Company from time to time party thereto (collectively, the “Subsidiary Guarantors”), the Lenders (as defined below) signatory thereto and Bank of America, N.A. as Administrative Agent (the “Agent”), which amends that certain Amended and Restated Credit Agreement, dated as of February 26, 2025 (the “Existing Credit Agreement” and, as amended by the Amendment, the “Credit Agreement”), by and among the Company, ABM UK, the Subsidiary Guarantors party thereto, the financial institutions party thereto from time to time as lenders (the “Lenders”) and the Agent.”

DSS, INC. entered into Underwriting Agreement with Aegis Capital Corp. (effective 2026-02-04).

“On February 4, 2026, DSS, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Aegis Capital Corp. (“Aegis”), which provided for the issuance and sale by the Company and the purchase by the underwriter, in a firm commitment underwritten public offering (the “Offering”), of 900,000 shares of the Company’s common stock, $0.02 par value per share.”

Toll Brothers, Inc. amended Term Loan Agreement (effective 2026-02-05).

“amendment, among other updates, the maturity date of $548,437,500 of loans outstanding under the Term Loan Agreement was extended from February 7, 2030 to February 5, 2031 (with $101,562,500 of outstanding loan remaining due on February 7, 2030) and the Term Loan Agreement’s interest rate provisions were adjusted to remove the SOFR Credit Spread Adjustment from substantially all outstanding loans thereunder.”

Toll Brothers, Inc. amended Revolving Credit Agreement (effective 2026-02-05).

“amendment, among other updates, the total amount of revolving loans and commitments available under the Revolving Credit Agreement was increased from $2.35 billion to $2.375 billion, the maturity date of the Revolving Credit Agreement was extended from February 7, 2030 to February 5, 2031, and the Revolving Credit Agreement’s interest rate provisions were adjusted to remove the Secured Overnight Financing Rate credit spread adjustment of ten basis points (the “SOFR Credit Spread Adjustment”).”

MITEK SYSTEMS INC terminated 0.750% Convertible Senior Notes due February 1, 2026 valued at $155,250,000 million in aggregate principal (effective 2026-02-01).

“On February 1, 2026, Mitek Systems, Inc. (the “Company”) repaid in full its 0.750% Convertible Senior Notes due February 1, 2026, which included $155,250,000 million in aggregate principal plus all accrued interest and terminated all lending commitments thereunder.”

STRATUS PROPERTIES INC amended Tenth Modification Agreement with Comerica Bank (effective 2026-01-30).

“Effective January 30, 2026, Stratus and certain of its wholly-owned subsidiaries named below (the Subsidiary Borrowers, and collectively with Stratus, the Borrowers), as borrowers, and Comerica Bank, as lender, entered into the Tenth Modification Agreement (the Tenth Modification), which amends that certain Loan Agreement dated June 29, 2018 by and between the Borrowers and Comerica Bank (the Loan Agreement), and that certain Second Amended and Restated Revolving Promissory Note dated March 25, 2025 by and between the Borrowers and Comerica Bank (the Note), each as previously amended.”

SMITH MICRO SOFTWARE, INC. entered into Note Agreement with Smith Living Trust valued at approximately $1,000,000 (effective 2026-02-03).

“On February 3, 2026, Smith Micro Software, Inc. (the “Company”) entered into a Note Purchase Agreement (the “Note Agreement”) with the Smith Living Trust, for which William W. Smith, Jr., the Company’s chairman, president and chief executive officer, and his wife, Dieva L. Smith, serve as co-trustees (“Smith”).”

SANGAMO THERAPEUTICS, INC entered into Underwriting Agreement with Cantor Fitzgerald & Co. and Wells Fargo Securities, LLC valued at approximately $25.0 million (effective 2026-02-03).

“On February 3, 2026, Sangamo Therapeutics, Inc. (“Sangamo” or the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Cantor Fitzgerald & Co. and Wells Fargo Securities, LLC”

COLUMBUS MCKINNON CORP entered into Indenture with Wilmington Trust, National Association, as trustee valued at $900.0 million in aggregate principal amount (effective 2026-01-30).

“The Notes were issued pursuant to an indenture, dated as of January 30, 2026 (the “Indenture”), between the Company and Wilmington Trust, National Association, as trustee (the “Trustee”) and as note collateral agent (the “Note Collateral Agent”).”

COLUMBUS MCKINNON CORP entered into New Credit Agreement with JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent valued at $1,650.0 million (effective 2026-02-03).

“On February 3, 2026, and in connection with the closing of the Kito Crosby Acquisition, the Company, Columbus McKinnon EMEA GmbH and certain other subsidiaries of the Company entered into a credit agreement (the “New Credit Agreement”) with the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent.”

VSE CORP entered into Underwriting Agreement with Jefferies LLC and RBC Capital Markets, LLC, acting as representatives of the several underwriters named therein valued at approximately $830.2 million (effective 2026-02-02).

“On February 2, 2026, VSE Corporation (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Jefferies LLC and RBC Capital Markets, LLC, acting as representatives of the several underwriters named therein (the “Underwriters”), pursuant to which the Company agreed to issue and sell (the “Offering”) 3,989,362 shares (the “Firm Shares”) of the Company’s common stock, par value $0.05 per share (the “Common Stock”), at a price to the public of $188.00 per share.”

SILICON LABORATORIES INC. entered into Agreement and Plan of Merger with Texas Instruments Incorporated, Caldwell Merger Corp. valued at $231.00 in cash, without interest.

“Silicon Laboratories Inc., a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Texas Instruments Incorporated, a Delaware corporation (“ Parent ”), and Caldwell Merger Corp., a Delaware and wholly-owned direct subsidiary of Parent (“ Merger Subsidiary ”), pursuant to which Merger Subsidiary will merge with and into the Company (the “ Merger ”), with the Company surviving the Merger as a wholly-owned direct subsidiary of Parent”

ALLIANCE RESOURCE PARTNERS LP entered into Purchase and Sale Agreement with The Kathleen S. Craft Foundation valued at $7.75 million purchase price; aggregate $15.5 million (effective 2026-01-29).

“On January 29, 2026, Alliance Resource Properties, LLC (“ Buyer ”), an indirect, wholly-owned subsidiary of Alliance Resource Partners, L.P. (“ ARLP ”), entered into separate purchase and sale agreements (each, a “ PSA ” and, collectively, the “ PSAs ”) with, respectively, The Joseph W. Craft III Foundation (the “ JWC Foundation ”) and The Kathleen S. Craft Foundation (the “ KSC Foundation ” and, together with the JWC Foundation, the “ Sellers ”)”

ALLIANCE RESOURCE PARTNERS LP entered into Purchase and Sale Agreement with The Joseph W. Craft III Foundation valued at $7.75 million purchase price; aggregate $15.5 million (effective 2026-01-29).

“On January 29, 2026, Alliance Resource Properties, LLC (“ Buyer ”), an indirect, wholly-owned subsidiary of Alliance Resource Partners, L.P. (“ ARLP ”), entered into separate purchase and sale agreements (each, a “ PSA ” and, collectively, the “ PSAs ”) with, respectively, The Joseph W. Craft III Foundation (the “ JWC Foundation ”) and The Kathleen S. Craft Foundation (the “ KSC Foundation ” and, together with the JWC Foundation, the “ Sellers ”)”

ORACLE CORP entered into Equity Distribution Agreement with BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, HSBC Securities (USA) Inc., BNP Paribas Securities Corp., PNC Capital Markets LLC, SMBC Nikko Securities America, Inc., Santander US Capital Markets LLC, TD Secur valued at $20.0 billion (effective 2026-02-02).

“On February 2, 2026, Oracle Corporation, a Delaware corporation ("Oracle") entered into an equity distribution agreement (the "Equity Distribution Agreement") with BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC, as sales agents, to sell shares of common stock, par value $0.01 per share, of Oracle (the "Common Stock") having aggregate sales proceeds of up to $20.0 billion (the "Shares"), from time to time, through an "at-the-market" offering program (the "ATM Offering").”

Orion Group Holdings Inc entered into First Amendment to the Loan Documents with guarantors party to the UMB Credit Agreement, lenders party thereto, UMB Bank, N.A., as administrative agent, and the Acquired Companies valued at approximately $46.9 million under Orion’s Credit Agreement (effective 2026-02-03).

“On February 3, 2026, Orion, the guarantors party to the UMB Credit Agreement, lenders party thereto and UMB Bank, N.A., as administrative agent and the Acquired Companies entered into a First Amendment to the Loan Documents, dated effective February 3, 2026 (the “First Amendment”)”

Orion Group Holdings Inc entered into Securities Purchase Agreement with Sellers (Shareholders, Members, Beneficial Owners), and Scott M. Vandegrift as representative valued at $50.0 million in cash; $12.0 million unsecured subordinated 5-year promissory note; 182,392 shares o (effective 2026-02-03).

“On February 3, 2026, Orion Group Holdings, Inc. (“Orion”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) and completed an acquisition (the “Acquisition”) of all of the capital stock of J.E. McAmis, Inc., a California corporation, and all of the membership interests in JEM Marine Leasing, LLC”

Vivakor, Inc. amended Forbearance and Note Amendment Agreements with seven non-affiliated accredited investors valued at approximately $2,242,793 (effective 2026-01-30).

“On January 30, 2026, the Company entered into Forbearance and Note Amendment Agreements (the “Agreements”) with the each of the seven investors.”

SITIME Corp entered into Commitment Letter with Wells Fargo Securities, LLC and Wells Fargo Bank, National Association valued at up to $900.0 million (effective 2026-02-04).

“In connection with its entry into the Asset Purchase Agreement, on February 4, 2026, the Company entered into a debt financing commitment letter (the "Commitment Letter") with Wells Fargo Securities, LLC and Wells Fargo Bank, National Association (collectively, "Wells Fargo"), pursuant to which Wells Fargo has committed to provide the Company with debt financing to fund a portion of the Cash Consideration in an aggregate principal amount of up to $900.0 million in the form of a 364-day senior secured bridge loan facility (the "Bridge Facility"), subject to customary conditions.”

SITIME Corp entered into Asset Purchase Agreement with Renesas Electronics America Inc. valued at approximately $1,500,000,000 in cash (effective 2026-02-04).

“On February 4, 2026, SiTime Corporation, a Delaware corporation ("SiTime" or the "Company") entered into an Asset Purchase Agreement (the "Asset Purchase Agreement") with Renesas Electronics America Inc., a California corporation ("Renesas"), pursuant to which Renesas will and will cause certain of its affiliates to sell, transfer, assign and convey to SiTime all of their right, title and interest in, to and under certain assets related to the timing business of Renesas Electronics Corporation (the "Business") for an aggregate purchase price of approximately $1,500,000,000 in cash ("Cash Consideration") and 4,130,644 shares of common stock”

XTI Aerospace, Inc. entered into Share Purchase and Transfer Agreement with EVO 467. GmbH valued at EUR 4,640,000 (approximately $5,475,000) (effective 2026-02-03).

“On February 3, 2026 (the “Signing Date” and the “Closing Date”), XTI Aerospace, Inc. (the “Company”) completed the disposition of the Inpixon Business (as defined below) pursuant to a Share Purchase and Transfer Agreement (the “SPA”) entered into on the same date with EVO 467. GmbH, a German limited liability company (the “Purchaser”).”

CION Investment Corp entered into Underwriting Agreement with Keefe, Bruyette & Woods, Inc., as representative of each of the several underwriters named in Schedule A thereto valued at $125.0 million aggregate principal amount (effective 2026-02-02).

“On February 2, 2026, CĪON Investment Corporation (“CION”) entered into an underwriting agreement (the “Underwriting Agreement”) with CION Investment Management, LLC, CION’s investment adviser, and Keefe, Bruyette & Woods, Inc., as representative of each of the several underwriters named in Schedule A thereto, in connection with the issuance and sale of $125.0 million aggregate principal amount of CION’s 7.50% Notes due 2031 (the “Notes”).”

PAVmed Inc. amended Amended and Restated 2022 Note (the "2026 Note") with the Holder valued at $15 million principal amount (effective 2026-02-03).

“Concurrently with the Offering, the Company redeemed all 16,962 shares of Series C Preferred Stock outstanding and refinanced all $8,414,890 in principal and interest of its Senior Secured Convertible Note issued in September (the “ 2022 Note ”), in consideration of a cash payment to the holder thereof (the “ Holder ”) of approximately $22,346,241 (which was made using proceeds from the sale of the Series D Preferred Stock), and the issuance to the Holder of an amended and restated 2022 Note (the “ 2026 Note ”) with a principal amount of $15 million.”

PAVmed Inc. entered into Subscription Agreements with certain accredited investors valued at $30 million aggregate purchase price (effective 2026-02-03).

“On February 3, 2026, PAVmed Inc. (the “ Company ”) entered into subscription agreements (the “ Subscription Agreements ”) with certain accredited investors (the “ Investors ”) and, pursuant to and concurrently with the execution of the Subscription Agreements, sold to the Investors, for an aggregate purchase price of $30 million, (i) 30,000 shares of the Company’s newly designated Series D Convertible Preferred Stock, par value $0.001 per share (the “ Series D Preferred Stock ”), and (ii) warrants (the “ Warrant ”) to purchase an additional 30,000 shares of Series D Preferred Stock, with each investor receiving 100 shares of Series D Preferred Stock and a warrant to purchase 100 shares of Series D Preferred Stock for each $100,000 of its investment (the “ Offering ”).”

Entera Bio Ltd. amended Amended and Restated Collaboration and License Agreement with OPKO Health, Inc. and OPKO Biologics Ltd. (effective 2026-02-03).

“On February 3, 2026, the Company and OPKO entered into an amended and restated collaboration and license agreement (the “ A&R Collaboration Agreement ”), which amends and restates the Original Collaboration Agreement to expand the scope of the agreement to include the collaboration with respect to the preclinical and clinical development of a daily long acting PTH tablet (“ LA-PTH ”) for the treatment of hypoparathyroidism and other indications in addition to the original oral dual agonist GLP-1/glucagon peptide program .”

Medalist Diversified, Inc. entered into Purchase and Sale Agreement with PC Acquisitions, LLC valued at $24,500,000 (effective 2026-02-03).

“On February 3, 2026, (the “Effective Date”), MDR Franklin Square, LLC, a Delaware limited liability company (the “Seller”), entered into a Purchase and Sale Agreement (the “Purchase and Sale Agreement”), with PC Acquisitions, LLC, a North Carolina limited liability company (the “Purchaser”), whereby the Purchaser agreed to acquire (the “Acquisition”) the Shops at Franklin Square, a 134,239 square foot retail property located in Gastonia, North Carolina (the “Franklin Square Property”).”

WRAP TECHNOLOGIES, INC. entered into Purchase Agreement with certain accredited investors valued at approximately $5 million (effective 2026-02-02).

“On February 2, 2026, Wrap Technologies, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain accredited investors (collectively, the “Purchasers”) for the issuance and sale in a private placement (the “Private Placement”) of (i) an aggregate of 1,700,000 shares (the “Common Shares”) of common stock of the Company, par value $0.0001 per share (the “Common Stock”), (ii) pre-funded warrants to purchase up to 800,000 shares of Common Stock (the “Pre-Funded Warrants”), with an exercise price of $0.0001 per share, and (iii) common warrants to purchase up to 2,500,000 shares of Common Stock (the “Common Warrants”, together with the Pre-Funded Warrants, the “Warrants”), with an exercise price of $2.30 per share.”

Dayforce, Inc. terminated Credit Agreement with JPMorgan Chase Bank, N.A., as collateral agent and administrative agent.

“Concurrently with the closing of the Merger, the Company terminated all commitments outstanding under, and repaid all outstanding loans and other amounts due under, the Credit Agreement, dated as of February 29, 2024 (as amended by that certain First Amendment to Credit Agreement, dated as of February 14, 2025, the “Credit Agreement”), by and among the Company, the lenders and other parties from time to time party thereto, and JPMorgan Chase Bank, N.A., as collateral agent and administrative agent (the “Agent”).”

Dayforce, Inc. terminated Capped Call Transactions with certain financial institutions (effective 2026-02-04).

“On February 4, 2026, the Company entered into unwind agreements with each Capped Call Counterparty pursuant to which, in the aggregate, all Capped Call Transactions were terminated in exchange for a nominal payment in favor of the Company.”

Dayforce, Inc. amended Convertible Notes Supplemental Indenture with Computershare Trust Company, N.A. (effective 2026-02-04).

“On February 4, 2026, the Company and Computershare Trust Company, N.A. (as successor to Wells Fargo Bank, National Association), as trustee (the “Trustee”), entered into the First Supplemental Indenture, dated as of February 4, 2026 (the “Convertible Notes Supplemental Indenture”) to the Indenture, dated as of March 5, 2021, by and between the Company and the Trustee (the “Convertible Notes Original Indenture” and, together with the Convertible Notes Supplemental Indenture, the “Convertible Notes Indenture”), relating to the Company’s 0.25% Convertible Senior Notes due 2026 (the “Convertible Notes”).”

Revolve Group, Inc. amended First Amendment to Amended and Restated Credit Agreement with Bank of America, N.A., as administrative agent and collateral agent for the Lenders (effective 2026-02-02).

“On February 2, 2026, Revolve Group, Inc. (the “Company”) entered into a First Amendment to Amended and Restated Credit Agreement (the “First Amendment”) to that certain Amended and Restated Credit Agreement, dated as of March 23, 2021”

UPEXI, INC. entered into Common Stock Sales Agreement with A.G.P./Alliance Global Partners (effective 2026-01-30).

“On January 30, 2026, Upexi, Inc., a Delaware corporation (the “Company”), entered into a Common Stock Sales Agreement (the “Sales Agreement”) with A.G.P./Alliance Global Partners (the “Sales Agent”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agent, shares of the Company’s common stock, par value $0.00001 per share (the “Common Stock”), in an “at-the-market” offering as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended (the “Securities Act”).”

GenFlat Holdings, Inc. entered into Underwriting Agreement with Craig-Hallum Capital Group LLC valued at total gross proceeds of approximately $7.0 million (effective 2026-02-02).

“On February 2, 2026, GenFlat Holdings, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Craig-Hallum Capital Group LLC, in its capacity as underwriter (the “ Underwriter ”), relating to the Company’s public offering (the “ Offering ”) of shares of common stock, par value $0.001 per share (the “ Common Stock ”) pursuant to the Company’s registration statement on Form S-1 (File No. 333 - 291718) (the “ Registration Statement ”), under the Securities Act of 1933, as amended (the “ Securities Act ”).”

Inspirato Inc terminated Capital One Note with Oakstone Ventures, Inc..

“At the Effective Time, Exclusive Investments acquired from Oakstone Ventures, Inc. (“ Oakstone Ventures ”) the 8% Senior Secured Convertible Note of the Company issued to Oakstone Ventures pursuant to the Investment Agreement dated August 7, 2023 (the “ Capital One Note ”), pursuant to the Note Termination Agreement entered into among the Company, its subsidiary Inspirato LLC (“ Inspirato LLC ”) and certain subsidiaries of Inspirato LLC, Oakstone Ventures and Capital One Services, LLC in connection with the execution of the Merger Agreement.”

Maze Therapeutics, Inc. entered into Loan and Security Agreement with Hercules Capital, Inc. valued at up to $200.0 million (effective 2026-02-04).

“On February 4, 2026 (the “ Closing Date ”), Maze Therapeutics, Inc. (the “ Company ”) entered into that certain Loan and Security Agreement (the “ Hercules Loan Agreement ”), by and among the Company, as borrower, the lenders from time to time party thereto, and Hercules Capital, Inc., in its capacity as administrative agent and collateral agent for itself and the lenders party thereto, which provides for a senior secured term loan facility in an aggregate principal amount of up to $200.0 million”

OKMIN RESOURCES, INC. entered into Agreement and Plan of Merger and Reorganization with BevPoint Capital LP (effective 2026-01-29).

“On January 29, 2026, Okmin Resources, Inc., a Nevada corporation ("Okmin" or the "Company"), entered into an Agreement and Plan of Merger and Reorganization with BPCAP Merger Sub, Inc., a Nevada corporation and wholly-owned subsidiary of Okmin ("Merger Sub"), and BevPoint Capital LP, a Florida limited partnership ("BevPoint").”

Maison Solutions Inc. entered into Buy-Sell Agreement with JC Business Guys, Inc. valued at $1.00 (effective 2026-01-31).

“On January 31, 2026, Maison Solutions Inc. (the "Company") entered into a Buy-Sell Agreement (the "Agreement") with JC Business Guys, Inc., a California corporation (the "Buyer").”

ARES STRATEGIC INCOME FUND amended Amendment No. 6 to Credit Agreement (the "SB Funding Facility Amendment") with The Bank of Nova Scotia valued at Increased total commitments from $750 million to $1.5 billion; extended reinvestment period to July (effective 2026-01-29).

“On January 29, 2026 (the “Closing Date”), Ares Strategic Income Fund (the “Fund”) as parent and servicer, ASIF Funding II, LLC, a wholly owned subsidiary of the Fund, as borrower ( “ASIF Funding II”) and The Bank of Nova Scotia, as administrative agent and revolving lender, entered into Amendment No. 6 to Credit Agreement (the “SB Funding Facility Amendment”) to the Credit Agreement, dated as of March 1, 2024 (as amended, the “SB Funding Facility”)”

VISTA CREDIT STRATEGIC LENDING CORP. amended Amendment No.1 to the Senior Secured Revolving Credit Agreement with ING Capital LLC valued at increase the total amount available to be borrowed under the Credit Agreement from $150,000,000 to $ (effective 2026-01-30).

“On January 30, 2026, Vista Credit Strategic Lending Corp. (the “Company”) entered (a) into the Amendment No.1 to the Senior Secured Revolving Credit Agreement (the “First Amendment"), which amends the Senior Secured Revolving Credit Agreement, dated as of September 5, 2025”

Fortress Net Lease REIT amended Fifth Amendment to Credit Agreement with Bank of America, N.A. valued at increased from $1,650,000,000 to $1,800,000,000 (effective 2026-01-29).

“On January 29, 2026, FNLR OP LP, as borrower (the “Borrower”), Fortress Net Lease REIT, as guarantor (the “Company”), the other guarantors party thereto (together with the Company, the “Guarantors” and, collectively with the Borrower, the “Loan Parties”), entered into that certain Fifth Amendment to Credit Agreement (the “Fifth Amendment”) with each lender party thereto and Bank of America, N.A., as administrative agent (the “Administrative Agent”), amending that certain Credit Agreement, initially dated August 13, 2024 and as most recently amended on November 20, 2025 (and as amended by the Fifth Amendment, the “Credit Agreement”), among the Loan Parties, the lenders party thereto and the Administrative Agent.”

Launch One Acquisition Corp. terminated Business Combination Agreement with Minovia Therapeutics Ltd. valued at Termination and Release Agreement entered into on January 30, 2026 mutually terminating the Business (effective 2026-01-30).

“Item 1.02 Termination of a Material Definitive Agreement. As previously disclosed, Launch One Acquisition Corp. (the “ Company ”) entered into a Business Combination Agreement, dated as of June 25, 2025, as amended on August 12, 2025, September 4, 2025, September 26, 2025 and January 6, 2026 (collectively, the “ BCA ”) with (i) Launch One Sponsor LLC, a Delaware limited liability company, in the capacity as the SPAC Representative (as defined in the BCA) under the BCA (the “ SPAC Representative ”), (ii) Minovia Therapeutics Ltd., an Israeli company limited by shares (“ Minovia ”), (iii) Natalie Yivgi-Ohana, in the capacity as the Seller Representative (as defined in the BCA) under the BCA (the “ Seller Representative ”), (iv) Mito US One Ltd., an Israeli company limited by shares (“ Pubco ”), and (v) Mito Sub Israel Ltd., an Israeli company limited by shares and a wholly-owned subsidiary of Pubco (“ Company Merger Sub ”).”